Showing posts with label biopharmaceutical. Show all posts
Showing posts with label biopharmaceutical. Show all posts

DNA Replication

{ Posted on 11:42 AM by rain }
DNA Replication
One major question for the human mind is how life continues. One of the most important mechanisms for all life cells to give offsprings is undoubtedly the DNA Replication. DNA Replication answers to the question: "When a cell divides, where the extra DNA comes from?". What "DNA Replication" is? It is the process that can duplicate the DNA of a cell. The next step is the cell to duplicate!
n the eukaryotes (organisms with cell that have nucleus) the DNA is formed in two strands, each composed of units called Nucleotides. The two strands look like two chains that form the DNA Double Helix. The DNA Replication Process is capable of opening the Double Helix and separating the two strands. Then the two strands are copied. As a result two new DNA molecules are created. The next step is the cell division. After that a daughter cell is created. In its nucleus lies a copy of the parental DNA.

Follow the links in the left menu in order to find more info about the DNA Replication Process.

Bio-Technology General - BTGC- Profile

{ Posted on 11:38 AM by rain }
Bio-Technology General Corp. The Group's principal activity is to conduct research, development, manufacture and marketing of biopharmaceutical products. The Group through the internal research, development and agreement has a portfolio of therapeutic products. The products include OXANDRIN (r), BIO-TROPINTM, BIOLON (r), DELATESTRYL (r), MIRCETTE (r) and others. OXANDRIN(R) is used for the treatment of weight loss due to severe trauma, chronic inflection, extensive surgery or unknown pathophysiology. BIO-TROPIN(TM) for the treatment of growth hormone deficiency in children or turner syndrome. BIOLON (R) is used for the protection of the corneal endothelium during ophthalmic surgery. DELATESTRYL (R), for the treatment of hypogonadism and delayed puberty. On 30-Sep-2002, it acquired Rosemont Pharmaceuticals Ltd. During the year 2001, the Group acquired Myelos Corporation. Product sales accounted for 97% of 2002 revenues; Contract fees, 2% and Other revenues, 1%.

...